Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Cover Image
Other Issues:
Previous Next
Contents: Volume 18, Number 1, January 2007   [Index by Author] 

Down in this issue
Down editorials
Down reviews
Down original articles
     epidemiology
     breast cancer
     gynecologic tumors
     gastrointestinal tumors
     lung cancer
     hematologic malignancies
     supportive care
     phase I and pharmacokinetics
Down letters to the editor


[Search ALL Issues]


Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

in this issue Back

in this issue
Ann Oncol 2007 18: 1; doi:10.1093/annonc/mdl474 [Extract] [Full Text] [PDF] [Request Permissions]  

editorials Back

DJ Kerr
Now the New Year reviving old desires
Ann Oncol 2007 18: 3; doi:10.1093/annonc/mdl486 [Extract] [Full Text] [PDF] [Request Permissions]  

MS Aapro
It is too early to know if intelligence determines cancer incidence and survival
Ann Oncol 2007 18: 4-5; doi:10.1093/annonc/mdl485 [Extract] [Full Text] [PDF] [Request Permissions]  

reviews Back

P Raanani, O Shpilberg, and I Ben-Bassat
Extramedullary disease and targeted therapies for hematological malignancies—is the association real?
Annals of Oncology Advance Access published on June 21, 2006
Ann Oncol 2007 18: 7-12; doi:10.1093/annonc/mdl129 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

N Fazio, F de Braud, G Delle Fave, and K Öberg
Interferon-{alpha} and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?
Annals of Oncology Advance Access published on June 23, 2006
Ann Oncol 2007 18: 13-19; doi:10.1093/annonc/mdl144 [Abstract] [FREE Full Text] [PDF] [CME/CE] [Request Permissions]  

original articles Back

epidemiology Back

GD Batty, K Modig Wennerstad, G Davey Smith, D Gunnell, IJ Deary, P Tynelius, and F Rasmussen
IQ in early adulthood and later cancer risk: cohort study of one million Swedish men
Ann Oncol 2007 18: 21-28; doi:10.1093/annonc/mdl473 [Abstract] [Full Text] [PDF] [Request Permissions]  

S-HI Ou, JA Zell, A Ziogas, and H Anton-Culver
Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 2007 18: 29-35; doi:10.1093/annonc/mdl320 [Abstract] [Full Text] [PDF] [Request Permissions]  

C Galeone, R Talamini, F Levi, C Pelucchi, E Negri, A Giacosa, M Montella, S Franceschi, and C La Vecchia
Fried foods, olive oil and colorectal cancer
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 2007 18: 36-39; doi:10.1093/annonc/mdl328 [Abstract] [Full Text] [PDF] [Request Permissions]  

S Gallus, L Scotti, E Negri, R Talamini, S Franceschi, M Montella, A Giacosa, L Dal Maso, and C La Vecchia
Artificial sweeteners and cancer risk in a network of case–control studies
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 2007 18: 40-44; doi:10.1093/annonc/mdl346 [Abstract] [Full Text] [PDF] [Request Permissions]  

breast cancer Back

HF Kennecke, IA Olivotto, C Speers, B Norris, SK Chia, C Bryce, and KA Gelmon
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 45-51; doi:10.1093/annonc/mdl334 [Abstract] [Full Text] [PDF] [Request Permissions]  

P Piedbois, D Serin, F Priou, P Laplaige, S Greget, E Angellier, E Teissier, J-F Berdah, M Fabbro, B Valenza, P Herait, V Jehl, and M Buyse
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study
Annals of Oncology Advance Access published on October 17, 2006
Ann Oncol 2007 18: 52-57; doi:10.1093/annonc/mdl355 [Abstract] [Full Text] [PDF] [Request Permissions]  

U Basso, L Fratino, A Brunello, F Lumachi, GL De Salvo, S Lonardi, C Ghiotto, H Koussis, LM Pasetto, and S Monfardini
Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
Annals of Oncology Advance Access published on October 6, 2006
Ann Oncol 2007 18: 58-63; doi:10.1093/annonc/mdl338 [Abstract] [Full Text] [PDF] [Request Permissions]  

L Perey, R Paridaens, H Hawle, K Zaman, F Nolé, H Wildiers, M Fiche, D Dietrich, P Clément, D Köberle, A Goldhirsch, and B Thürlimann
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 64-69; doi:10.1093/annonc/mdl341 [Abstract] [Full Text] [PDF] [Request Permissions]  

gynecologic tumors Back

J Kodama, Hasengaowa, T Kusumoto, N Seki, T Matsuo, Y Ojima, K Nakamura, A Hongo, and Y Hiramatsu
Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer
Annals of Oncology Advance Access published on October 10, 2006
Ann Oncol 2007 18: 70-76; doi:10.1093/annonc/mdl342 [Abstract] [Full Text] [PDF] [Request Permissions]  

gastrointestinal tumors Back

T André, C Tournigand, L Mineur, R Fellague-Chebra, M Flesch, M Mabro, M Hebbar, S Postel Vinay, FC Bidard, C Louvet, and A de Gramont
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 77-81; doi:10.1093/annonc/mdl336 [Abstract] [Full Text] [PDF] [Request Permissions]  

AD Wagner, P Buechner-Steudel, A Wein, H Schmalenberg, U Lindig, M Moehler, R Behrens, G Kleber, O Kuss, and WE Fleig
Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 82-87; doi:10.1093/annonc/mdl340 [Abstract] [Full Text] [PDF] [Request Permissions]  

J Lee, WK Kang, JM Kwon, SY Oh, HR Lee, HJ Kim, BB Park, HY Lim, MJ Han, JO Park, and YS Park
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 2007 18: 88-92; doi:10.1093/annonc/mdl317 [Abstract] [Full Text] [PDF] [Request Permissions]  

C-C Lin, C-H Hsu, JC Cheng, H-P Wang, J-M Lee, K-H Yeh, C-H Yang, J-T Lin, A-L Cheng, and Y-C Lee
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
Annals of Oncology Advance Access published on October 6, 2006
Ann Oncol 2007 18: 93-98; doi:10.1093/annonc/mdl339 [Abstract] [Full Text] [PDF] [Request Permissions]  

lung cancer Back

N van Zandwijk, A Mathy, L Boerrigter, H Ruijter, I Tielen, D de Jong, P Baas, S Burgers, and P Nederlof
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 2007 18: 99-103; doi:10.1093/annonc/mdl323 [Abstract] [FREE Full Text] [PDF] [Request Permissions]  

U Seifart, T Fink, C Schade-Brittinger, K Hans, C Mueller, G Koschel, H Schroeder, R Lorenz, J Dethling, and M Wolf
Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 2007 18: 104-109; doi:10.1093/annonc/mdl353 [Abstract] [Full Text] [PDF] [Request Permissions]  

CP Belani, S Dakhil, DM Waterhouse, CE Desch, DK Rooney, RH Clark, MJ Monberg, Z Ye, and CK Obasaju
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 2007 18: 110-115; doi:10.1093/annonc/mdl344 [Abstract] [Full Text] [PDF] [Request Permissions]  

hematologic malignancies Back

A Belch, CT Kouroukis, M Crump, L Sehn, RD Gascoyne, R Klasa, J Powers, J Wright, and EA Eisenhauer
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 2007 18: 116-121; doi:10.1093/annonc/mdl316 [Abstract] [Full Text] [PDF] [Request Permissions]  

H Narimatsu, Y Ota, M Kami, K Takeuchi, R Suzuki, K Matsuo, T Matsumura, K Yuji, Y Kishi, T Hamaki, U Sawada, S Miyata, T Sasaki, K Tobinai, M Kawabata, Y Atsuta, Y Tanaka, R Ueda, and S Nakamura
Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 2007 18: 122-128; doi:10.1093/annonc/mdl349 [Abstract] [Full Text] [PDF] [Request Permissions]  

KM Ramadan, T Shenkier, LH Sehn, RD Gascoyne, and JM Connors
A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 2007 18: 129-135; doi:10.1093/annonc/mdl329 [Abstract] [Full Text] [PDF] [Request Permissions]  

C Nickenig, M Dreyling, E Hoster, W-D Ludwig, B Dörken, M Freund, C Huber, A Ganser, L Trümper, R Forstpointner, M Unterhalt, and W Hiddemann
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas—results of a randomized comparison by the German Low-Grade Lymphoma Study Group
Annals of Oncology Advance Access published on October 27, 2006
Ann Oncol 2007 18: 136-142; doi:10.1093/annonc/mdl348 [Abstract] [Full Text] [PDF] [Request Permissions]  

G Gorini, E Stagnaro, V Fontana, L Miligi, V Ramazzotti, D Amadori, S Rodella, R Tumino, P Crosignani, C Vindigni, A Fontana, P Vineis, and A Seniori Costantini
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case–control study
Annals of Oncology Advance Access published on October 17, 2006
Ann Oncol 2007 18: 143-148; doi:10.1093/annonc/mdl352 [Abstract] [Full Text] [PDF] [Request Permissions]  

V Boehme, S Zeynalova, M Kloess, M Loeffler, U Kaiser, M Pfreundschuh, and N Schmitz
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 2007 18: 149-157; doi:10.1093/annonc/mdl327 [Abstract] [Full Text] [PDF] [Request Permissions]  

supportive care Back

AA Martoni, C Degli Esposti, A Cricca, G Rocchi, and S Giaquinta
Twice-daily pain monitoring as standard clinical practice for inpatients at a medical oncology unit: a descriptive study
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 2007 18: 158-162; doi:10.1093/annonc/mdl314 [Abstract] [Full Text] [PDF] [Request Permissions]  

R Catane, A Beck, Y Inbar, T Rabin, N Shabshin, S Hengst, RM Pfeffer, A Hanannel, O Dogadkin, B Liberman, and D Kopelman
MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases—preliminary clinical experience
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 163-167; doi:10.1093/annonc/mdl335 [Abstract] [Full Text] [PDF] [Request Permissions]  

J Alexandre, E Rey, V Girre, S Grabar, A Tran, V Montheil, F Rabillon, V Dieras, V Jullien, P Hérait, G Pons, J-M Treluyer, and F Goldwasser
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study
Annals of Oncology Advance Access published on October 23, 2006
Ann Oncol 2007 18: 168-172; doi:10.1093/annonc/mdl321 [Abstract] [Full Text] [PDF] [Request Permissions]  

SH Ahn, BW Park, DY Noh, SJ Nam, ES Lee, MK Lee, SH Kim, KM Lee, SM Park, and YH Yun
Health-related quality of life in disease-free survivors of breast cancer with the general population
Annals of Oncology Advance Access published on October 9, 2006
Ann Oncol 2007 18: 173-182; doi:10.1093/annonc/mdl333 [Abstract] [Full Text] [PDF] [Request Permissions]  

DY Aksoy, MD Tanriover, O Uzun, P Zarakolu, S Ercis, S Ergüven, A Oto, U Kerimoglu, M Hayran, and O Abbasoglu
Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis
Annals of Oncology Advance Access published on October 5, 2006
Ann Oncol 2007 18: 183-189; doi:10.1093/annonc/mdl337 [Abstract] [Full Text] [PDF] [Request Permissions]  

phase I and pharmacokinetics Back

S Mani, HM McDaid, A Grossman, F Muggia, S Goel, T Griffin, D Colevas, SB Horwitz, and MJ Egorin
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone
Annals of Oncology Advance Access published on October 3, 2006
Ann Oncol 2007 18: 190-195; doi:10.1093/annonc/mdl315 [Abstract] [Full Text] [PDF] [Supplementary Material] [Request Permissions]  

letters to the editor Back

TE Delea, J Karnon, and PE Goss
Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 2007 18: 197-198; doi:10.1093/annonc/mdl171 [Extract] [Full Text] [PDF] [Request Permissions]  

E Lonning
Reply to ‘Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature’ by Delea et al.
Annals of Oncology Advance Access published on July 27, 2006
Ann Oncol 2007 18: 198-199; doi:10.1093/annonc/mdl170 [Extract] [Full Text] [PDF] [Request Permissions]  

A Carmona-Bayonas
Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer
Annals of Oncology Advance Access published on September 15, 2006
Ann Oncol 2007 18: 199-200; doi:10.1093/annonc/mdl290 [Extract] [Full Text] [PDF] [Request Permissions]  

M Bebenek
EUROCARE study underestimated the curability of breast cancer in Poland
Annals of Oncology Advance Access published on October 4, 2006
Ann Oncol 2007 18: 200-201; doi:10.1093/annonc/mdl291 [Extract] [Full Text] [PDF] [Request Permissions]  

D Santini, B Vincenzi, M Caraglia, and G Tonini
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss
Annals of Oncology Advance Access published on October 4, 2006
Ann Oncol 2007 18: 201-202; doi:10.1093/annonc/mdl298 [Extract] [Full Text] [PDF] [Request Permissions]  

U De Giorgi, G Rosti, L Frassineti, B Kopf, N Giovannini, F Zumaglini, and M Marangolo
High-dose chemotherapy for triple negative breast cancer
Annals of Oncology Advance Access published on September 13, 2006
Ann Oncol 2007 18: 202-203; doi:10.1093/annonc/mdl306 [Extract] [Full Text] [PDF] [Request Permissions]  

D Generali, R Leek, SB Fox, JW Moore, C Taylor, P Chambers, and AL Harris
EGFR mutations in exons 18–21 in sporadic breast cancer
Ann Oncol 2007 18: 203-205; doi:10.1093/annonc/mdl322 [Extract] [Full Text] [PDF] [Request Permissions]  

M Conti-Beltraminelli, O Pagani, G Ballerini, A Richetti, R Graffeo, M Ruggeri, V Forni, S Pianca, C Schönholzer, C Mainetti, F Cavalli, and A Goldhirsch
Henoch–Schönlein purpura (HSP) during treatment with anastrozole
Annals of Oncology Advance Access published on October 16, 2006
Ann Oncol 2007 18: 205-207; doi:10.1093/annonc/mdl350 [Extract] [Full Text] [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.